Pfizer Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Apr 2017 | $36.33B | $58.44B | $4.06B |
| Jul 2017 | $34.19B | $58.37B | $2.59B |
| Oct 2017 | $34.50B | $60.77B | $2.78B |
| Dec 2017 | $33.54B | $71.31B | $1.34B |
| Apr 2018 | $31.83B | $70.18B | $2.30B |
| Jul 2018 | $28.94B | $69.78B | $2.70B |
| Sep 2018 | $33.65B | $71.32B | $3.56B |
| Dec 2018 | $32.91B | $63.41B | $1.14B |
| Mar 2019 | $35.73B | $58.81B | $1.94B |
| Jun 2019 | $36.17B | $59.57B | $1.78B |
| Sep 2019 | $36.04B | $65.10B | $2.79B |
| Dec 2019 | $35.96B | $63.14B | $1.12B |
| Mar 2020 | $36.28B | $65.03B | $2.15B |
| Jun 2020 | $50.53B | $64.34B | $1.80B |
| Sep 2020 | $49.79B | $65.26B | $1.59B |
| Dec 2020 | $37.13B | $63.24B | $1.79B |
| Apr 2021 | $35.35B | $68.62B | $1.77B |
| Jul 2021 | $35.35B | $70.04B | $2.37B |
| Oct 2021 | $36.25B | $75.69B | $1.97B |
| Dec 2021 | $36.20B | $77.20B | $1.94B |
| Apr 2022 | $35.66B | $82.42B | $2.47B |
| Jul 2022 | $34.29B | $87.21B | $1.78B |
| Oct 2022 | $32.63B | $92.63B | $1.30B |
| Dec 2022 | $32.88B | $95.66B | $416.0M |
| Apr 2023 | $31.70B | $100.97B | $2.17B |
| Jul 2023 | $61.36B | $99.02B | $2.63B |
| Oct 2023 | $61.05B | $96.93B | $3.15B |
| Dec 2023 | $61.54B | $89.01B | $2.85B |
| Mar 2024 | $61.31B | $92.28B | $719.0M |
| Jun 2024 | $57.51B | $87.70B | $1.05B |
| Sep 2024 | $58.00B | $92.29B | $1.09B |
| Dec 2024 | $57.41B | $88.20B | $1.04B |
| Mar 2025 | $57.64B | $90.34B | $1.43B |
| Jun 2025 | $57.50B | $88.70B | $1.64B |
| Sep 2025 | $57.41B | $92.80B | $1.34B |
| Dec 2025 | $61.64B | $86.48B | $1.14B |
| Mar 2026 | $60.57B | $90.10B | $1.70B |
| Jun 2026 | $60.50B | $85.19B | $976.0M |